Physician profile
Michael Walkovich
NPI 1538162136
$3,347.22
in general payments reported to CMS, 2019-2025
27 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $100 · 2021: $148 · 2022: $301 · 2023: $257 · 2024: $666 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,295.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $621.66 | 2019-2025 | Citrefix, Variax, Swanson |
| Smith+Nephew, INC. | $447.82 | 2019-2025 | Grafix, Stravix, Grafix Pl |
| Integra Lifesciences Corporation | $406.92 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Surgenex LLC | $352.66 | 2025 | Surgraft, Surmatrix, Pellograft |
| Treace Medical Concepts, INC. | $262.27 | 2025 | |
| Paragon 28, INC. | $249.93 | 2019-2025 | Additive Orthopedics, R3flex, Portfolio |
| Medtronic USA, INC. | $123.91 | 2019 | |
| Ani Pharmaceuticals, INC. | $104.84 | 2024 | Purified Cortrophin Gel |
| Depuy Synthes Sales INC. | $102.74 | 2019-2025 | Hammerlock |
| Convatec INC. | $93.95 | 2023-2025 | |
| Medtronic, INC. | $84.00 | 2024 | Intellis Adaptivestim |
| Access Pro Medical, LLC | $71.95 | 2025 | Matriderm |
| Organogenesis INC. | $69.31 | 2021-2025 | Puraply Wound Matrix, Cygnus Dual |
| Zimmer Biomet Holdings, INC. | $47.34 | 2019-2022 | |
| Abbott Laboratories | $35.74 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $35.12 | 2024 | Nuzyra |
| Nevro Corp. | $33.27 | 2023 | Senza |
| Acell, INC. | $32.76 | 2019-2020 | |
| Horizon Therapeutics Plc | $31.93 | 2021-2022 | |
| Bioventus LLC | $28.97 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Osteomed LLC | $20.21 | 2020 | |
| Avanos Medical | $17.47 | 2023 | |
| Amgen INC. | $17.10 | 2025 | Krystexxa |
| Acera Surgical, INC. | $15.62 | 2019 | |
| Alfasigma USA, INC. | $13.41 | 2022 | |
| Arthrosurface Incorporated | $13.32 | 2019 | |
| Celularity INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Walkovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.